Fibromyalgic syndromes: could growth hormone therapy be beneficial
Published work links its activity to nitric-oxide pathway signaling, FAK-paxillin cell-adhesion pathways, growth-factor receptor expression, and dopaminergic and serotonergic systems
The scientists reported that, on average, liraglutide leads to an almost 5kg (~11lb) greater weight loss compared to placebo
Singles on GLP-1 medications reported going on 60% more dates per month after starting treatment, averaging 1.6 dates per month compared to 1.0 before
Reviewed by Courtney Floyd, MD, Physician at Ivm Health Disclaimers: This information is for educational purposes only and does not constitute medical advice
Currently in clinical trials, Retatrutide is showing even greater potential for weight loss and diabetes management